Inactive Instrument

Philab Holdings Corp.

DNA

PHY6900R1015

Advanced Medical Equipment & Technology

Philab Holdings Corp. Announces Resignation of Robert W. van Zwieten, President and CEO

July 12, 2020 at 07:18 pm EDT

Philab Holdings Corp. announced Robert W. van Zwieten, President and CEO, has resigned from these positions with immediate effect on July 10, 2020.

Latest news about Philab Holdings Corp.

Philab Holdings Corp. Announces Board Changes	20-07-12	CI
Philab Holdings Corp. Announces Resignation of Robert W. van Zwieten, President and CEO	20-07-12	CI
Philab Holdings Corporation and Prenetics Limited Sign Memorandum of Agreement	19-12-16	CI
Philab Holdings Corporation has Changed its Name to DNA Holdings Corporation	19-12-16	CI
Philab Holdings Corp. Elects Jose Miguel Vergara as Acting Chairman	19-12-08	CI
Philab Holdings Corp. Announces Resignation of Thomas Hector Navasero as Chairman of the Board	19-12-05	CI
Philab Holdings Corp. Announces Labor Case Regarding Illegal Dismissal	19-12-04	CI
Philab Holdings Corp. Announces Unaudited Consolidated Earnings Results for the Third Quarter Ended Sep. 30, 2019	19-11-19	CI
Philab Holdings Corp. Announces Unaudited Consolidated Earnings Results for the Second Quarter Ended June 30, 2019	19-11-11	CI
Philab Holdings Corp. Announces Unaudited Consolidated Earnings Results for the Year Ended December 31, 2018	19-11-11	CI
Philab Holdings Corp. Reports Earnings Results for the First Quarter Ended March 31, 2018	19-11-05	CI
Philab Holdings Corp. Appoints Atty Jason C. Esperante as Corporate Secretary of the Company	19-10-30	CI
Philab Holdings Corp. Announces Resignation of Hector Thomas Navasero as Chairman	19-10-08	CI
Philab Holdings Corp. Announces Executive Appointments	19-09-30	CI
Philab Holdings Corp. Announces Management Appointments	19-09-19	CI
Philab Holdings Corp. Announces Retirement of Executives	19-09-05	CI
Philab Holdings Corp. Announces Resignation of Edgardo Faylona as Independent Director	19-08-28	CI
Philab Holdings Corp. Announces Management Changes	19-07-25	CI
Hector Thomas A. Navasero acquired 24.24% stake in Philab Holdings Corp. from Rewa Romina Cristina L. Santos for approximately PHP 130 million.	19-07-23	CI
Philab Holdings Corp. Announces the Resignation of Arlene R Castillo as Corporate Information Officer and Chief of Staff	19-06-26	CI
Philab Holdings Corp. Announces Change in Corporate Business Address	19-04-23	CI
Philab Holdings Corp. Appoints Atty. Geraldine Elaine D. Laqui as Assistant Corporate Secretary	19-02-13	CI
Philab Holdings Corp. Reports Earnings Results for the First Nine Months of 2018; Provides Profitability Guidance for the Year 2019	18-12-16	CI
Philab Holdings Corp. cancelled the acquisition of 66.66% stake in Sydenham Laboratories Inc.	18-12-10	CI
Philab Holdings Corp. Announces Resignation of Sylvia A. Navasero as Director and Treasurer	18-12-03	CI

Philab Holdings Corp., formerly Alterra Capital Partners, Inc., is a holding company. The Company conducts its business through its subsidiary, Philab Industries, Inc. (Philab). Philab is engaged in the healthcare sector, particularly the life sciences tools and services industry, by supplying laboratory equipment, furniture, and supplies for medical and scientific research to both private and public institutions. Its life sciences tools include laboratory equipment and supplies, such as autoclaves, microscopes, fume hoods, reagents, and learning materials. Its life sciences services include delivery, installation, maintenance, repair and upgrade of life sciences tools. Its In Vitro Diagnostic are medical devices and accessories used for the diagnosis of communicable and non-communicable diseases. It has its own brand of self-test kits, LabIt, designed to be used in one's own home. It is also focused on providing Whole Genome Sequencing and healthcare management-related services.

Sector

Advanced Medical Equipment & Technology

More about the company